Hematopoietic Stem Cell Transplantation and Hematopoietic Stem Cell Gene Therapy in X-linked Adrenoleukodystrophy

Overview

Journal Brain Pathol

Date 2010 Jul 15

PMID 20626747

Citations 56

Authors

Nathalie Cartier

Patrick Aubourg

Affiliations

Soon will be listed here.

Abstract

Allogeneic hematopoietic stem cell transplantation (HSCT) is the only therapeutic approach that can arrest cerebral demyelination of X-linked adrenoleukodystrophy (ALD) in boys and results in long-term in a good quality of life, provided the procedure is performed at an early stage of disease. Similar benefits of allogeneic HSCT have been demonstrated in adults with cerebral ALD. However, it is not yet known whether allogeneic HSCT can prevent or rescue adrenomyeloneuropathy. Allogeneic HSCT remains associated with significant morbidity and mortality risks, particularly in adults, and not all ALD patients have donors despite the availability of cord blood. The absence of biological markers that can predict the evolutivity of cerebral disease is a major limitation to propose in due time allogeneic HSCT to ALD patients. Recently, HSC gene therapy using lentiviral vector was shown to have comparable efficacy than allogeneic HSCT in two boys with cerebral ALD who had no Human-leukocyte-antigen (HLA)-matched donor. If these results are confirmed in an extended series of patients, HSC gene therapy may become the first therapeutic option for all ALD male patients who develop cerebral demyelination.

Citing Articles

Practical Approach to Longitudinal Neurologic Care of Adults With X-Linked Adrenoleukodystrophy and Adrenomyeloneuropathy.

Kornbluh A, Baldwin A, Fatemi A, Vanderver A, Adang L, Van Haren K Neurol Genet. 2024; 10(5):e200192.

PMID: 39372123 PMC: 11450743. DOI: 10.1212/NXG.0000000000200192.

Pathophysiology of X-Linked Adrenoleukodystrophy: Updates on Molecular Mechanisms.

Parasar P, Kaur N, Singh J J Biotechnol Biomed. 2024; 7(2):277-288.

PMID: 39056013 PMC: 11271253. DOI: 10.26502/jbb.2642-91280151.

The pathology of X-linked adrenoleukodystrophy: tissue specific changes as a clue to pathophysiology.

Yska H, Engelen M, Bugiani M Orphanet J Rare Dis. 2024; 19(1):138.

PMID: 38549180 PMC: 10976706. DOI: 10.1186/s13023-024-03105-0.

An empowered, clinically viable hematopoietic stem cell gene therapy for the treatment of multisystemic mucopolysaccharidosis type II.

Das S, Rruga F, Montepeloso A, Dimartino A, Spadini S, Corre G Mol Ther. 2024; 32(3):619-636.

PMID: 38310355 PMC: 10928283. DOI: 10.1016/j.ymthe.2024.01.034.

Efficacy of HDAC Inhibitors in Driving Peroxisomal β-Oxidation and Immune Responses in Human Macrophages: Implications for Neuroinflammatory Disorders.

Villoria-Gonzalez A, Zierfuss B, Parzer P, Heubock E, Zujovic V, Waidhofer-Sollner P Biomolecules. 2023; 13(12).

PMID: 38136568 PMC: 10741867. DOI: 10.3390/biom13121696.

References

Hitomi T, Mezaki T, Tomimoto H, Ikeda A, Shimohama S, Okazaki T . Long-term effect of bone marrow transplantation in adult-onset adrenoleukodystrophy. Eur J Neurol. 2005; 12(10):807-10. DOI: 10.1111/j.1468-1331.2005.01055.x. View

Hacein-Bey-Abina S, Garrigue A, Wang G, Soulier J, Lim A, Morillon E . Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. J Clin Invest. 2008; 118(9):3132-42. PMC: 2496963. DOI: 10.1172/JCI35700. View

Gaspar H, Parsley K, Howe S, King D, Gilmour K, Sinclair J . Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector. Lancet. 2004; 364(9452):2181-7. DOI: 10.1016/S0140-6736(04)17590-9. View

Naldini L, Blomer U, Gallay P, Ory D, Mulligan R, Gage F . In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science. 1996; 272(5259):263-7. DOI: 10.1126/science.272.5259.263. View

Peters C, Charnas L, Tan Y, Ziegler R, Shapiro E, DeFor T . Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999. Blood. 2004; 104(3):881-8. DOI: 10.1182/blood-2003-10-3402. View

Ajami B, Bennett J, Krieger C, Tetzlaff W, Rossi F . Local self-renewal can sustain CNS microglia maintenance and function throughout adult life. Nat Neurosci. 2007; 10(12):1538-43. DOI: 10.1038/nn2014. View

Aiuti A, Vai S, Mortellaro A, Casorati G, Ficara F, Andolfi G . Immune reconstitution in ADA-SCID after PBL gene therapy and discontinuation of enzyme replacement. Nat Med. 2002; 8(5):423-5. DOI: 10.1038/nm0502-423. View

Shapiro E, Krivit W, Lockman L, Jambaque I, Peters C, Cowan M . Long-term effect of bone-marrow transplantation for childhood-onset cerebral X-linked adrenoleukodystrophy. Lancet. 2000; 356(9231):713-8. DOI: 10.1016/S0140-6736(00)02629-5. View

Okamura K, Watanabe T, Onishi T, Watanabe H, Fujii E, Mori K . Successful allogeneic unrelated bone marrow transplantation using reduced-intensity conditioning for the treatment of X-linked adrenoleukodystrophy in a one-yr-old boy. Pediatr Transplant. 2008; 13(1):130-3. DOI: 10.1111/j.1399-3046.2008.00962.x. View

10.

Davoust N, Vuaillat C, Androdias G, Nataf S . From bone marrow to microglia: barriers and avenues. Trends Immunol. 2008; 29(5):227-34. DOI: 10.1016/j.it.2008.01.010. View

11.

Hacein-Bey-Abina S, von Kalle C, Schmidt M, McCormack M, Wulffraat N, Leboulch P . LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science. 2003; 302(5644):415-9. DOI: 10.1126/science.1088547. View

12.

Mosser J, Douar A, Sarde C, Kioschis P, Feil R, Moser H . Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters. Nature. 1993; 361(6414):726-30. DOI: 10.1038/361726a0. View

13.

Krall W, Challita P, Perlmutter L, Skelton D, Kohn D . Cells expressing human glucocerebrosidase from a retroviral vector repopulate macrophages and central nervous system microglia after murine bone marrow transplantation. Blood. 1994; 83(9):2737-48. View

14.

Mildner A, Schmidt H, Nitsche M, Merkler D, Hanisch U, Mack M . Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions. Nat Neurosci. 2007; 10(12):1544-53. DOI: 10.1038/nn2015. View

15.

Lange M, Teive H, Troiano A, Bitencourt M, Funke V, Setubal D . Bone marrow transplantation in patients with storage diseases: a developing country experience. Arq Neuropsiquiatr. 2006; 64(1):1-4. DOI: 10.1590/s0004-282x2006000100001. View

16.

Beam D, Poe M, Provenzale J, Szabolcs P, Martin P, Prasad V . Outcomes of unrelated umbilical cord blood transplantation for X-linked adrenoleukodystrophy. Biol Blood Marrow Transplant. 2007; 13(6):665-74. DOI: 10.1016/j.bbmt.2007.01.082. View

17.

Tsirigotis P, Shapira M, Or R, Bitan M, Samuel S, Gesundheit B . The number of infused CD34+ cells does not influence the incidence of GVHD or the outcome of allogeneic PBSC transplantation, using reduced-intensity conditioning and antithymocyte globulin. Bone Marrow Transplant. 2009; 45(7):1189-96. DOI: 10.1038/bmt.2009.331. View

18.

Krivit W, Aubourg P, Shapiro E, Peters C . Bone marrow transplantation for globoid cell leukodystrophy, adrenoleukodystrophy, metachromatic leukodystrophy, and Hurler syndrome. Curr Opin Hematol. 1999; 6(6):377-82. DOI: 10.1097/00062752-199911000-00004. View

19.

de Palma M, Montini E, Santoni de Sio F, Benedicenti F, Gentile A, Medico E . Promoter trapping reveals significant differences in integration site selection between MLV and HIV vectors in primary hematopoietic cells. Blood. 2004; 105(6):2307-15. DOI: 10.1182/blood-2004-03-0798. View

20.

Borker A, Yu L . Unrelated allogeneic bone marrow transplant in adrenoleukodystrophy using CD34+ stem cell selection. Metab Brain Dis. 2002; 17(3):139-42. DOI: 10.1023/a:1019969820308. View